Design of a multi-epitope vaccine candidate against carrion disease by immunoinformatics approach

• Autores: Rivera-Asencios, Damaris, Espinoza-Culupú, Abraham, Carmen-Sifuentes, Sheyla, Ramirez, Pablo, García-de-la-Guarda, Ruth
• Formato: artículo
• Fecha de Publicación: 2024
• Institución: Universidad Nacional Mayor de San Marcos
• Repositorio: UNMSM-Tesis
• Lenguaje: inglés
• OAI Identifier: oai:cybertesis.unmsm.edu.pe:20.500.12672/27424
• Enlace del recurso: https://hdl.handle.net/20.500.12672/27424; https://doi.org/10.1016/j.compbiomed.2024.109397
• Nivel de acceso: acceso abierto
• Materia: Multiepítopo; Vacuna; Inmunoinformática; Bartonella bacilliformis; https://purl.org/pe-repo/ocde/ford#1.06.03

Carrion's disease, caused by the bacterium Bartonella bacilliformis, is a serious public health problem in Peru, Ecuador and Colombia. Currently there is no available vaccine against B. bacilliformis. While antibiotics are the standard treatment, resistant strains have been reported, and there is a potential spread of the vector that transmits the bacteria. This study aimed to design a multi-epitope vaccine candidate against the causative agent of Carrion's disease using immunoinformatics tools. Predictions of B-cell epitopes, as well as CD4+ and CD8+T cell epitopes, were performed from the entire proteome of B. bacilliformis KC583 using the most frequent alleles from Peru, Ecuador, Colombia, and worldwide. B-cell epitopes and T-cell nested epitopes from outer membrane and virulence-associated proteins were selected. Epitopes were filtered out based on promiscuity, non-allergenicity, conservation, non-homology and non-toxicity. Two vaccine constructs were assembled using linkers. The tertiary structure of the constructs was predicted, and their stability was evaluated through molecular dynamics simulations. The most stable construct was selected for molecular docking with the TLR4 receptor. This study proposes a vaccine construct evaluated in silico as a potential vaccine candidate against Bartonella bacilliformis.